CD8A and neoplasm: F. nucleatum inhibits the expression of PD‐1 in CD8+ TILs by synthesizing butyrate and epigenetically activating the TBX21 transcription factor, thereby increasing cytotoxicity of CD8+ TILs and tumor cell killing.